Shorstein Neal H, Carolan James, Liu Liyan, Alexeeff Stacey E, Amsden Laura B, Herrinton Lisa J
From the Departments of Ophthalmology and Quality, Kaiser Permanente, Walnut Creek, California (Shorstein); Department of Ophthalmology, Kaiser Permanente San Rafael, California (Carolan); Division of Research, Kaiser Permanente Northern California, Oakland, California (Liu, Alexeeff, Amsden, Herrinton).
J Cataract Refract Surg. 2021 Jul 1;47(7):870-877. doi: 10.1097/j.jcrs.0000000000000542.
To compare visual outcomes in patients without a history of macular edema after phacoemulsification using combination topical nonsteroidal anti-inflammatory drug plus prednisolone with prednisolone alone.
Kaiser Permanente Northern California, USA.
Retrospective cohort study.
Information was obtained from the electronic health record. The first measure of corrected distance visual acuity (CDVA) recorded during the period 3 weeks to 1 year after phacoemulsification was obtained. Confounding factors and clustering of eyes within patients were adjusted using linear mixed effects regression models for the continuous outcome of CDVA improvement and general estimating equations for the dichotomous outcome of 20/20 or better vs 20/25 or worse.
The study included 62 700 health plan members of whom 26,309 (42%) used topical prednisolone alone, whereas 36,391 (58%) used combination treatment. The mean within-person change in CDVA from the preoperative measurement to the postoperative measurement was the same (-0.43 logMAR) for patients in the 2 groups. However, the group that received combination treatment was somewhat more likely to achieve CDVA of 20/20 or better (odds ratio 1.24 with 95% CI, 1.20-1.28).
In this large study of cataract surgery patients, a small statistically significant association of combination treatment compared with prednisolone alone was observed.
比较在白内障超声乳化术后无黄斑水肿病史的患者中,局部使用非甾体类抗炎药联合泼尼松龙与单独使用泼尼松龙的视觉效果。
美国北加利福尼亚州凯撒医疗集团。
回顾性队列研究。
从电子健康记录中获取信息。获取白内障超声乳化术后3周内至1年期间记录的首次矫正远视力(CDVA)测量值。对于CDVA改善这一连续结果,使用线性混合效应回归模型对混杂因素及患者双眼聚类情况进行校正;对于20/20及以上与20/25及以下这一二分结果,使用广义估计方程进行校正。
该研究纳入了62700名健康计划成员,其中26309名(42%)单独使用局部泼尼松龙,而36391名(58%)使用联合治疗。两组患者从术前测量到术后测量的CDVA平均个体内变化相同(-0.43 logMAR)。然而,接受联合治疗的组更有可能达到20/20或更好的CDVA(优势比1.24,95%可信区间为1.20 - 1.28)。
在这项针对白内障手术患者的大型研究中,观察到联合治疗与单独使用泼尼松龙相比存在小的统计学显著关联。